Tech Company Financing Transactions

Symptomly Funding Round

On 8/25/2014, Symptomly landed $200 thousand in funding from private investors.

Transaction Overview

Company Name
Announced On
8/25/2014
Transaction Type
Online Capital
Online Capital
Amount
$200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Not an offer or solicitation for sale of securities. Please contact technology company for solicitation details.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
450 S Simmons Way
Kaysville, UT 84037
USA
Email Address
Not Recorded
Overview
Symptomly is focused on improving the lives of those who suffer with chronic disease. Symptomly provides tools for hospitals and insurance providers to manage their chronic disease population outside the clinical setting where the vast majority of symptoms present themselves.
Profile
Symptomly LinkedIn Company Profile
Social Media
Symptomly Company Twitter Account
Company News
Symptomly News
Facebook
Symptomly on Facebook
YouTube
Symptomly on YouTube

Management Team

Title
Name
Email & Social
Co-Founder
Derek Bereit
  Derek Bereit LinkedIn Profile  Derek Bereit Twitter Account  Derek Bereit News  Derek Bereit on Facebook
VP - Operations
Bob Durkin
  Bob Durkin LinkedIn Profile  Bob Durkin Twitter Account  Bob Durkin News  Bob Durkin on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/25/2014: Civitas Therapeutics venture capital transaction
Next: 8/25/2014: Meedoc venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary